Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
TLDR
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results, however, no differences have been found in terms of impact factor.Abstract:
Objectives
Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications.
Methods and Findings
All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61–2·56) for studies with results classified as positive and 3·21 years (IC95 2·69–3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55–2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141–28·409) and negative result studies (median 8·266, interquartile range: 4·135–17·157).
Conclusions
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.read more
Citations
More filters
Posted ContentDOI
Integrating omics approaches to discover and prioritize candidate genes involved in oil biosynthesis in soybean
Dayana K. Turquetti-Moraes,Kanhu C. Moharana,Fabricio Almeida-Silva,Francisnei Pedrosa-Silva,Thiago M. Venancio +4 more
TL;DR: In this paper, the co-occurrence of genomic regions for oil-related traits in different studies may reveal more stable regions encompassing important genetic determinants of oil content and quality in soybean.
Posted ContentDOI
Mosaic evolution of molecular pathways for sex pheromone communication in a butterfly
Caroline M. Nieberding,Patrícia Beldade,Patrícia Beldade,Véronique Baumle,Gilles San Martin,Alok Arun,Georges Lognay,Nicolas Montagné,Lucie Bastin-Héline,Emmanuelle Jacquin-Joly,Céline Noirot,Christophe Klopp,Bertanne Visser +12 more
TL;DR: The results suggest that a mosaic pattern best explains how sex pheromone communication evolved in butterflies, with some molecular components derived from moths, and others conserved from more ancient insect ancestors.
Posted ContentDOI
MHC*IMP - Imputation of Alleles for Genes in the Major Histocompatibility Complex
David McG. Squire,Allan Motyer,Richard Ahn,Joanne Nitiham,Zhi-Ming Huang,Jorge R. Oksenberg,Wilson Liao,Stephen Leslie +7 more
TL;DR: The development of MHC*IMP, a method for imputing non-classical HLA and other genes in the human Major Histocompatibility Complex (MHC), performs very well, with allele prediction accuracy 93% or greater for all but two of the genes, and greater than 95% for allbut four.
Posted ContentDOI
A high-quality genome assembly and annotation of the humpback grouper Cromileptes altivelas
Yunpeng Sun,Dabing Zhang,Jue Shi,G. F. Chen,Yuzhang Wu,Youqing Shen,Zhiwei Cao,L.D. Zhang,Yu-Guang Zhou +8 more
TL;DR: In this article, a chromosome-level genome assembly and annotation of the humpback grouper genome using more than 103X PacBio long-reads and high-throughput chromosome conformation capture (Hi-C) technologies was reported.
Posted ContentDOI
Comparison between an exact and a heuristic neural mass model with second order synapses
TL;DR: In this article , the authors show that NMM1 is an approximation of NMM2 in the infinitely slow synapse limit and evaluate the applicability of this limit in the context of realistic physiological parameter values.
References
More filters
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and should provide the reader with the ability to make informed judgments regarding the internal and external validity of the trial.
Journal ArticleDOI
Publication bias in clinical research
TL;DR: The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.
Journal ArticleDOI
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
TL;DR: The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.